ArticleCardiovascular and interventional radiology2025
Lattice Flow Diverter for the Treatment of Unruptured Intracranial Aneurysms: A Retrospective Study.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lattice innovative flow diverter with mechanical balloons: a new breakthrough and efficacy evaluation in the treatment of unruptured intracranial aneurysms.Frontiers in medicine · 2025Article
- Lattice flow diverter for the treatment of small and medium-sized anterior circulation aneurysms.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeFlow diverters (FDs) represent an innovative approach distinct from traditional intra-aneurysm embolization for endovascular treatment. Recently, various types of FDs have been developed and extensively applied in managing intracranial aneurysms. This study evaluates the safety and efficacy of a new FD (Lattice) for treating unruptured intracranial aneurysms.
methodsThis retrospective study collected cases of unruptured intracranial aneurysms treated with Lattice flow diverter (LFD) from May 2023 to July 2024. Patient demographics, aneurysm specifics, procedure details, complications, occlusion rates, and clinical outcomes were assessed.
resultsThis study included 44 aneurysms from 40 patients. The LFD was successfully placed in all cases, with 15 aneurysms (34.1%) also undergoing coil embolization. Procedure-related complications included mild cerebral infarction in 1 patient (2.5%). Neointimal hyperplasia (NIH) was found in two patients during the follow-up angiography 6 months after the implantation of the LFD. One patient was mild and the other was severe. And these two patients did not have any ischemic symptoms. Moreover, one patient experienced complete stent occlusion at the final follow-up, also without ischemic symptoms. The average follow-up duration was 7.15 months (5.00, 14.00), with a 72.7% complete occlusion rate and an mRS score of 0 for all patients.
conclusionsIn this limited series, the novel LFD appeared safe and effective for treating unruptured intracranial aneurysms, demonstrating promising short-term aneurysm occlusion rates. However, additional research with larger sample sizes and long-term follow-up is needed to confirm these findings.
Indexed as
Identifiers
40281243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.